S'abonner

Responsiveness of an activity tracker as a measurement tool in a knee osteoarthritis clinical trial (ACTIVe-OA study) - 06/12/21

Doi : 10.1016/j.rehab.2021.101619 
Shirley P. Yu, MBBS, MPH, FRACP a, , Manuela L. Ferreira, BPhty, MSc, PhD a, Vicky Duong, BSc, DPT a, Jimmy Caroupapoullé, MSc b, Nigel K. Arden, MD, PhD c, d, Kim L. Bennell, BAppSci (Physio), PhD e, David J. Hunter, MBBS, FRACP, PhD a
a Department of Rheumatology, Royal North Shore Hospital and Institute of Bone and Joint Research, Kolling Institute, University of Sydney, Sydney, New South Wales, Australia 
b Faculty of Engineering and Physical Sciences, University of Southampton, Southampton, United Kingdom 
c Centre for Sport, Exercise and Osteoarthritis Versus Arthritis, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, United Kingdom 
d MRC Lifecourse Epidemiology Unit, Southampton General Hospital, University of Southampton, Southampton, United Kingdom 
e Centre for Health, Exercise and Sports Medicine, Department of Physiotherapy, School of Health Sciences, Faculty of Medicine Dentistry & Health Sciences, The University of Melbourne, Melbourne, Victoria, Australia 

Corresponding author. Shirley Yu, Department of Rheumatology, Royal North Shore Hospital, Reserve Road, St Leonards, NSW 2065, AUSTRALIADepartment of RheumatologyRoyal North Shore HospitalReserve RoadSt LeonardsNSW 2065AUSTRALIA
Sous presse. Manuscrit accepté. Disponible en ligne depuis le Monday 06 December 2021
Cet article a été publié dans un numéro de la revue, cliquez ici pour y accéder

Highlights

This is the first osteoarthritis clinical trial to utilise activity tracker-recorded outcomes.
Activity trackers are a feasible measurement tool in a clinical trial context.
Behavioural and physical activity change was observed via step count and load rate.
Activity tracker-recorded outcomes did not show significant responsiveness or validity.

Le texte complet de cet article est disponible en PDF.

Abstract

Background. In osteoarthritis (OA) clinical trials, reliable and responsive outcome measures to document physical and functional improvements are limited.

Objective. This study aimed to assess whether the use of an activity tracker in an OA clinical trial is a responsive measurement tool. Secondary objectives assessed feasibility and validity.

Methods. We recruited 65 participants in a prospective cohort study nested in a placebo-controlled clinical trial of platelet-rich plasma injection in knee OA. Participants wore an activity tracker (Fitbit Flex 2), and a smartphone was preloaded with a mobile application (OApp) designed to monitor load rates as a surrogate of knee loading. Participants used the systems for 7 days at baseline and for 7 days before the 2-month follow-up assessment. Effect size (ES) and standardised response mean (SRM) were calculated for change in step count and knee loading rate and regularly used knee OA outcome measures. Correlation coefficients (r) were calculated to examine the strength of the association between outcome measures.

Results. Step count showed a trivial ES and SRM and mean knee loading rate measurements a moderate ES and SRM. We found a weak but significant correlation between change in mean steps per day and global improvement overall (r = 0.28) and Western Western Ontario and McMaster Universities Osteoarthritis Index function (r = -0.28). Compliance was high with the activity trackers.

Conclusions. Despite good feasibility, this study did not show significant responsiveness or validity of the activity trackers as compared with currently recommended outcome measures in OA clinical trials. The main challenge is the lack of a gold standard outcome measure to validate against, and because of the complex interplay between pain and measured function, a lack of correlation does not necessarily represent a failed validation in this context.

Australian New Zealand Clinical Trials Registry: ACTRN12617000853347. This trial is a substudy of the “Platelet-rich plasma as a symptom-and disease-modifying treatment for knee osteoarthritis – the RESTORE trial”.

Le texte complet de cet article est disponible en PDF.

Keywords : Osteoarthritis, Fitness trackers, Activity trackers, Smartphones, Outcome assessment


Plan


© 2021  Publié par Elsevier Masson SAS.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.